BOSTON and LAUSANNE, Switzerland — SOPHiA GENETICS SA, the creator of a global data pooling and knowledge sharing platform that advances data-driven medicine, announced today the pricing of its initial public offering of 13,000,000 ordinary shares at a price of $18 per share. The gross proceeds from the offering, before deducting underwriting discounts and commissions […]
TOKYO — OriCiro Genomics, a pioneer in cell-free synthesis and amplification of genome-scale large DNA for advanced therapy and synthetic biology, today announced that it has raised ¥800 million in Series B financing led by The University of Tokyo Edge Capital Partners (UTEC) with participation of ITOCHU Technology Ventures (ITV). OriCiro has also received a ¥200 million […]
Capital Partners to Expand Commercial Activities and Accelerate Product Development CHADDS FORD, Pa. — MOBILion Systems Inc., a pioneer in fast, efficient, highresolution instrumentation for biomarker discovery, diagnostics and biotherapeutic drug characterization, today announced the close of a $60 million Series C financing round. The round was led by D1 Capital Partners with the remaining funds contributed by existing investors […]
The winning technology will detect dangerous contents in drugs and help save lives Ottawa, ON | Health Canada The overdose crisis continues to affect communities and families across Canada. Tragically, Canada has experienced higher rates of overdoses since the onset of COVID-19, due in part to the increasing toxicity of the illegal drug supply. […]
Pleasanton, Calif.—Apton Biosystems, Inc., a developer of Super-Res sequencing and single-molecule detection systems for large-scale clinical applications, such as early cancer detection and population sequencing, today announced the close of a $24 million Series-A financing. The financing was led by Kern Capital with participation by new and existing investors including Casdin Capital and Khosla Ventures. […]
Element Biosciences, developer of a new and disruptive DNA sequencing platform, today announced the close of a $276 million Series C financing. New investors Janus Henderson Investors, Logos Capital, Meritech Capital Partners, Counterpoint Global (Morgan Stanley), and T. Rowe Price joined existing investors Fidelity Management & Research Company, Foresite Capital, JS Capital Management LLC, RA Capital Advisors, and Venrock. With this latest investment, Element Biosciences […]
Wellington, New Zealand – Wellington-based deep tech startup Marama Labs has secured $1.25m in new funding in a round co-led by US-based venture capital firm Quidnet Ventures and New Zealand Growth Capital Partners (NZGCP), with support from several New Zealand investors. Marama Labs’ chemical analysis tools give industrial customers, such as wineries, unique chemical insights […]
We are delighted to have been awarded a grant of up to £320,000 from Innovate UK, the UK’s innovation agency, for the research and development of a 100L bioreactor for stem cell applications. Our existing range Our existing range of patented airlift, single-use bioreactors includes the CellMaker Systems: Regular, Low Flow and Plus – created […]
Defined recently received a $1.5M in Phase II SBIR award from the National Institutes of Health to develop defined media over the next two years. The funded project aims to make further improvements on HiDef-B8, the company’s flagship product and fully defined medium supplement for human induced pluripotent stem (iPS) cells. First published by the […]
Highlights Trajan Group Holdings Limited raises $90 million in an Initial Public Offering (IPO) Strong investor demand attracting top tier Australian, Asian, UK and NZ institutions 300+ employees participate via employee gift and ESOP, reflecting Trajan’s ‘people first’ culture Listing confirmed for 7th June 2021, 10.30am Melbourne, Australia – Global analytical science and device company […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
